InfuSystem to host investor webcast Sept. 24
InfuSystem will hold an investor webcast on September 24, 2026 to present its strategy, business model and growth initiatives with live investor Q&A.
Rhea-AI Filing Summary
InfuSystem Holdings, Inc. (INFU) announced that it will host an investor webcast presentation on September 24, 2026 at 2:00 p.m. Eastern Time. The event will feature an introductory presentation by President and CEO Carrie Lachance and EVP/CFO Barry Steele covering the company’s corporate strategy, business model and growth initiatives.
Following the formal presentation, investors will be able to submit questions through an interactive Q&A portal. Access to the webcast will be provided via a Zoom registration link and through the company’s investor relations website. The related press release is furnished as an exhibit to this report under a Regulation FD disclosure.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Webcast date: September 24, 2026
Webcast time: 2:00 p.m. Eastern Time
Exhibits furnished: 2 exhibits
+1 more
4 metrics
Webcast date
September 24, 2026
Scheduled date of InfuSystem’s investor webcast presentation
Webcast time
2:00 p.m. Eastern Time
Scheduled start time of the investor webcast
Exhibits furnished
2 exhibits
Exhibit 99.1 press release and Exhibit 104 cover page interactive data file
Report date
September 17, 2026
Date InfuSystem announced the investor webcast and signed the report
Key Terms
Regulation FD Disclosure, forward-looking statements, durable medical equipment, Patient Services, +2 more
6 terms
Regulation FD Disclosure regulatory
"Item 7.01 - Regulation FD Disclosure On September 17, 2026, InfuSystem Holdings, Inc."
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
forward-looking statements regulatory
"Certain statements contained in this press release are forward-looking statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
durable medical equipment medical
"facilitating outpatient care for durable medical equipment manufacturers and health care providers"
Durable medical equipment (DME) includes long-lasting devices used to help people manage health conditions and improve mobility, such as wheelchairs, hospital beds, and oxygen machines. These items are designed to be reused and are often covered by health insurance. For investors, DME represents a steady market because demand remains consistent as populations age and healthcare needs grow.
Patient Services financial
"The first platform is Patient Services, providing the last-mile solution"
Device Solutions financial
"The second platform, Device Solutions, supports the Patient Services platform"
Centers of Excellence other
"operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario"
Centers of excellence are specialized teams or departments within an organization that focus on developing and applying expert knowledge or skills in a particular area. They serve as hubs for best practices, innovation, and high-quality performance, much like a master chef’s kitchen dedicated to perfecting a specific cuisine. For investors, these centers can signal a company’s commitment to excellence and innovation, potentially influencing its long-term success and stability.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did InfuSystem Holdings, Inc. (INFU) announce in this Form 8-K?
InfuSystem announced that it will host an investor webcast presentation on September 24, 2026 at 2:00 p.m. Eastern Time. The session will include an introductory presentation on corporate strategy, business model and growth initiatives, followed by a Q&A via an interactive portal.
When is InfuSystem (INFU) holding its investor webcast and at what time?
The investor webcast is scheduled for Thursday, September 24, 2026 at 2:00 p.m. Eastern Time. Investors can access the event through a Zoom registration link and via InfuSystem’s investor relations website.
Who will present during InfuSystem’s September 24, 2026 investor webcast?
The webcast will feature Carrie Lachance, President and Chief Executive Officer, and Barry Steele, Executive Vice President and Chief Financial Officer. They will deliver an introductory presentation on InfuSystem’s business and growth initiatives before opening an investor Q&A session.
How can investors access InfuSystem’s September 24, 2026 webcast?
Investors can register via a Zoom webinar link provided in the announcement and access a link to the webcast on InfuSystem’s investor relations website at https://ir.infusystem.com.
What topics will InfuSystem (INFU) cover during the investor webcast?
Management plans to cover key aspects of InfuSystem’s corporate strategy, business model and growth initiatives. After the prepared remarks, investors will have an opportunity to ask relevant questions via an interactive Q&A portal.
What business model does InfuSystem (INFU) describe in this disclosure?
InfuSystem describes a two-platform model: Patient Services, which includes Oncology, Pain Management and Wound Therapy, and Device Solutions, which provides direct payer rentals, pump and consumable sales, and biomedical services and repair.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): September 17, 2026
___________________________________
(Exact name of registrant as specified in its charter)
___________________________________
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||
(Address of principal executive offices) (Zip Code) | ||||||||
( | ||||||||
(Registrant's telephone number, including area code) | ||||||||
Not Applicable | ||||||||
(Former Name or Former Address, if Changed Since Last Report) | ||||||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on which Registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 - Regulation FD Disclosure
On September 17, 2026 , InfuSystem Holdings, Inc. (the “Company”) issued a press release announcing that it will host an investor webcast presentation on Thursday, September 24, 2026 at 2:00 p.m. Eastern Time. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information furnished in this Item 7.01 — “Regulation FD Disclosure” of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Item 9.01 - Financial Statements and Exhibits
(d) Exhibits
Exhibit No. | Description | |||||||
99.1 | Press Release of InfuSystem Holdings, Inc. dated September 17, 2026 | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INFUSYSTEM HOLDINGS, INC. | |||||
By: | /s/ Barry Steele | ||||
Barry Steele | |||||
Chief Financial Officer | |||||
Dated: September 17, 2026
Exhibit 99.1
 | InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 (248) 291-1210 | Contact: Barry Steele Chief Financial Officer (248) 260-2211 | ||||||
InfuSystem to Host Investor Webcast
on September 24, 2026
Rochester Hills, Michigan, September 17, 2026 - InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that it will host an investor webcast presentation on Thursday, September 24, 2026 at 2:00 p.m. Eastern Time.
During the webcast, Carrie Lachance, President and Chief Executive Officer, and Barry Steele, Executive Vice President and Chief Financial Officer, will conduct an introductory presentation covering key aspects of InfuSystem’s business, including corporate strategy, business model, and growth initiatives. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal.
Participants can register here: https://us02web.zoom.us/webinar/register/WN_3xY_SK3RSC-FfkfxFlk-7w
A link to the webcast will also be available on InfuSystem’s website at https://ir.infusystem.com.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.
Forward-Looking Statements
Certain statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions,
business plans, strategic partnerships, growth initiatives, objectives and prospects, future operating or financial performance, guidance and expected new business relationships and the terms thereof (including estimated potential revenue under new or existing contracts). The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “goal,” “expect,” “strategy,” “future,” “likely,” variations of such words, and other similar expressions, as they relate to the Company, are intended to identify forward-looking statements. Forward-looking statements are subject to factors, risks and uncertainties that could cause actual results to differ materially, including, but not limited to, our ability to successfully execute on our growth initiatives and strategic partnerships, our ability to enter into definitive agreements for new business relationships on expected terms or at all, our ability to generate estimated potential revenue amounts under new or existing contracts, our dependence on estimates of collectible revenue, potential litigation, changes in third-party reimbursement processes, changes in law, global financial conditions and recessionary risks, rising inflation and interest rates, supply chain disruptions, systemic pressures in the banking sector, including disruptions to credit markets, contributions from acquired businesses or new business lines, products or services and other risk factors disclosed in the Company’s most recent annual report on Form 10-K and, to the extent applicable, quarterly reports on Form 10-Q. Our strategic partnerships are subject to similar factors, risks and uncertainties. All forward-looking statements made in this press release speak only as of the date hereof. We do not undertake any obligation to update any forward-looking statements to reflect future events or circumstances, except as required by law.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
####